Evidence map›Paper›PMID 29616210›Full record

ReviewFrontiers in chemistry2018

Natural Products Research in China From 2015 to 2016.

Haishan Liu, Guoliang Zhu, Yaqin Fan, Yuqi Du, Mengmeng Lan, Yibo Xu, Weiming Zhu

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. 3-Acta pharmaceutica Sinica. B · 2020
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haishan LiuSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Guoliang ZhuSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Yaqin FanSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Yuqi DuSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Mengmeng LanSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Yibo XuSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Weiming ZhuSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review covers the literature published by chemists from China during the 2015-2016 on natural products (NPs), with 1,985 citations referring to 6,944 new compounds isolated from marine or terrestrial microorganisms, plants, and animals. The emphasis is on 730 new compounds with a novel skeleton or/and significant bioactivity, together with their source organism and country of origin.

Indexed as

bioactivityChinanatural productsnovel skeletonstructure

Identifiers

PMID29616210
PMCPMC5869933

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.